Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19

被引：11

作者：

Accorsi, Patrizia ^{[1
]}

Berti, Pierluigi ^{[2
]}

de Angelis, Vincenzo ^{[3
]}

De Silvestro, Giustina ^{[4
]}

Mascaretti, Luca ^{[5
]}

Ostuni, Angelo ^{[6
]}

机构：

[1] Dept Haematol Transfus Med & Biotechnol, Osped Civile, Pescara, Italy

[2] Umberto Parini Hosp, Immunohaematol & Transfus Med, Aosta, Italy

[3] Azienda Sanit Univ Friuli Cent, Transfus Med Dept, Udine, Italy

[4] Univ Hosp Padua, Blood Transfus Serv, Padua, Italy

[5] Azienda Sanit Univ Giuliano Isontina, Transfus Med Dept, Trieste, Italy

[6] Univ Hosp Policlin, Transfus Med Unit, Bari, Italy

来源：

TRANSFUSION AND APHERESIS SCIENCE | 2020年 / 59卷 / 04期

关键词：

COVID-19; Immune plasma; CONVALESCENT PLASMA; THERAPY;

D O I：

10.1016/j.transci.2020.102817

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Passive immunotherapy with plasma derived from patients convalescent from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that Blood Establishments are prepared to satisfy requests for immune plasma by defining the requirements applicable to plasma donors and the standards for preparation, qualification, storage, distribution and control of use of the product. This position paper is aimed to give recommendations on biological characteristics of a plasma preparation from convalescent donors and to support the evaluation of this therapeutic approach in more rigorous investigations.

引用

页数：3

共 19 条

[1] [Anonymous], US CONV WHOL BLOOD P
[2] Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
Arabi, Yaseen
Balkhy, Hanan
Hajeer, Ali H.
Bouchama, Abderrezak
Hayden, Frederick G.
Al-Omari, Awad
Al-Hameed, Fahad M.
Taha, Yusri
Shindo, Nahoko
Whitehead, John
Merson, Laura
AlJohani, Sameera
Al-Khairy, Khalid
Carson, Gail
Luke, Thomas C.
Hensley, Lisa
Al-Dawood, Abdulaziz
Al-Qahtani, Saad
Modjarrad, Kayvon
Sadat, Musharaf
Rohde, Gernot
Leport, Catherine
Fowler, Robert
[J]. SPRINGERPLUS, 2015, 4 : 1 - 8
[3] The convalescent sera option for containing COVID-19
Casadevall, Arturo
Pirofski, Liise-Anne
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (04) : 1545 - 1548
[4] Convalescent plasma as a potential therapy for COVID-19
Chen, Long
Xiong, Jing
Bao, Lei
Shi, Yuan
[J]. LANCET INFECTIOUS DISEASES, 2020, 20 (04) : 398 - 400
[5] Use of convalescent plasma therapy in SARS patients in Hong Kong
Cheng, Y
Wong, R
Soo, YOY
Wong, WS
Lee, CK
Ng, MHL
Chan, P
Wong, KC
Leung, CB
Cheng, G
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (01) : 44 - 46
[6] Clinical Trials.gov, 2020, HYP PLASM CRIT PAT C
[7] Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines
Crowe, JE
Firestone, CY
Murphy, BR
[J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (07) : 3910 - 3918
[8] Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients
Duan, Jun
Han, Xiaoli
Bai, Linfu
Zhou, Lintong
Huang, Shicong
[J]. INTENSIVE CARE MEDICINE, 2017, 43 (02) : 192 - 199
[9] European Directorate for the Quality of Medicines and HealthCare, 2017, GUIDE PREPARATION US, V20th
[10] The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
Mair-Jenkins, John
Saavedra-Campos, Maria
Baillie, J. Kenneth
Cleary, Paul
Khaw, Fu-Meng
Lim, Wei Shen
Makki, Sophia
Rooney, Kevin D.
Nguyen-Van-Tam, Jonathan S.
Beck, Charles R.
[J]. JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (01) : 80 - 90

← 1 2 →